Bixiye
Angiotensin II Receptor Antagonists (ARBs), Renin Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 2071 - 2080 ee natiijooyinka 3690
Bixiye
QP75-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Weight Loss Agents
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
Triptan - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Topiramate ER - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Pulmonary Arterial Hypertension - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Compounded Medications - Commercial
Formulary Exception, Coverage Exception
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Opioids Extended Release (ER) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Northera® (droxidopa) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024